$WEED The Cannabis ETF

Top 5 Holdings ( as of 4/20/2022 )

Overview

Roundhill believes that continued legalization by both U.S. states and foreign governments globally result in an attractive growth profile for the cannabis sector.

$61B

Legal cannabis sales expected globally by 20261

37

Number of states cannabis is currently legal in2

 

 

The Roundhill Cannabis ETF ("WEED ETF") is designed to offer investors exposure to the cannabis sector. The fund invests in various cannabis related companies, including: (i) cannabis producers and distributors, (ii) cannabis-related technology companies, and (iii) additional cannabis related ancillary businesses.

More +

The Roundhill Cannabis ETF may utilize total return swaps to provide exposure to U.S. focused cannabis companies. Total return swaps are over-the-counter derivatives which provide the fund with exposure to the underlying reference assets (i.e. MSOs). Total return swaps introduce counterparty risk via prime brokers that the Fund engages with.

WEED May Provide Exposure To:
  • U.S. multi-state operators ("MSOs") like Curaleaf, Trulieve, GTI, and Verano, by gaining exposure via total return swaps.
  • Ancillary cannabis businesses such as Leafly, WM Technology (Weedmaps), and Innovative Industrial Properties.
  • Foreign cannabis companies, including Canadian operators such as Tilray and Canopy Growth.
Cannabis Sector Highlights:
  • The global legal cannabis market is expected to generate more than $61 billion in sales by 2026, more than doubling 2021's $29 billion in sales.(BDSA)
  • Cannabis is currently legal in some form in 37 U.S. states and Washington D.C, including 18 states which have regulated recreational markets. Positive regulatory momentum is expected to continue in coming years, with the densely populated Tri-State market (Connecticut, New York, New Jersey) expected to come online in 2022 and 2023. Legal U.S. cannabis sales are expected to surpass $28 billion in 2022. (Bloomberg Intelligence, BDSA)
  • Cannabis remains illegal at the federal level in the United States and potential federal legalization would represent a significant tailwind for the sector. In April 2022, the U.S. House of Representatives passed the MORE Act, which would serve to decriminalize cannabis on a federal level.

Fund
Details

Ticker

WEED

Primary Exchange

Cboe BZX

Gross Expense Ratio

0.75%

Net Expense Ratio

0.59%*

AUM

Launch

4/20/22

# of Holdings

ETF Options

YES

Securities Lending

NO

Shares Outstanding

Performance

As of TBD

 

Net Asset Value

Change ($)

Change (%)

1 Year

As of

Since Inception (4/20/22)

As of

 

Closing Price

Change ($)

Change (%)

1 Year

As of

Since Inception (4/20/22)

As of

*The Advisor has agreed to waive 0.16% of its management fee for the Fund until at least April 30, 2023

The performance data quoted represents past performance. Past performance does not guarantee future results. Current performance may be lower or higher than the performance data quoted. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost. Returns less than one year are not annualized. For the most recent month-end performance, please call (855) 561-5728. You cannot invest directly in an index. Shares are bought and sold at market price (closing price), not net asset value (NAV), and are individually redeemed from the Fund. Market performance is determined using the Primary Exchange official closing price. Brokerage commissions will reduce returns

Top Holdings & Documents

Name Ticker Weight

View All +

 

ETF holdings and allocations are subject to change at any time and should not be interpreted as an offer of these securities.

Premium/Discount

 

 

NAV

Premium/Discount

30-Day Median Bid/Ask Spread

0.2495%

FAQs

$WEED The Cannabis ETF